Effect of Extracorporeal Shock Wave Therapy After Arthroscopic Rotator Cuff Repair
Overview
Although radial extracorporeal shock wave therapy (rESWT) has proven to be an effective treatment, the effectiveness of the treatment has so far been controversial. There are no studies using rESWT in rehabilitation after arthroscopic rotator cuff repair (ARCR). Therefore, in this study, there is evidence that rESWT promotes pain control and healing recovery, and through previous studies, we would like to investigate whether treatment with rESWT during the intensive rehabilitation period of patients after ARCR is more effective in controlling pain.
Study Type
- Study Type: Interventional
- Study Design
- Allocation: N/A
- Intervention Model: Single Group Assignment
- Primary Purpose: Treatment
- Masking: None (Open Label)
- Study Primary Completion Date: June 30, 2021
Interventions
- Behavioral: Radial extracorporeal shockwave therapy
- Radial extracorporeal shockwave therapy group include Therapeutic modality(Transcutaneous electrical nerve stimulation [TENS], Microwave thermotherapy, and Superficial heat therapy), Range of motion exercise(Continuous passive motion and Active range of motion exercise).
Arms, Groups and Cohorts
- Experimental: Radial extracorporeal shockwave therapy
Clinical Trial Outcome Measures
Primary Measures
- . Pain intensity
- Time Frame: Change from baseline pain intensity at 2 weeks
- A numeric pain rating scale (NPRS) consisting of 11 points in total from 0 points (no pain) to 10 points (the most severe pain imaginable) is used. The lower the score, the less the pain.
Participating in This Clinical Trial
Inclusion Criteria
- Adults over 18 years old – In case of 6 weeks after receiving arthroscopic rotator cuff repair – When the participants wishes to enroll in the study Exclusion Criteria:
- 65 years old or older – If the tear area is large and augmentation is performed – If there is a previous surgical history at the surgical site – Osteoarthritis in the shoulder joint
Gender Eligibility: All
Minimum Age: 19 Years
Maximum Age: 65 Years
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Sahmyook University
- Provider of Information About this Clinical Study
- Principal Investigator: Hyun-Joong Kim, Principal investigator – Sahmyook University
- Overall Official(s)
- Hyun-Joong Kim, MSc, Principal Investigator, Principal Investigator
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.